Skip to content
Screener

Reported August 13, 2025 · Before market open

EPS-$0.40In line
EPS estimate-$0.40

Next report

Nov 11, 2026 (in 2 months)
EPS estimate-$0.29

FAQ

When did Immuneering Corporation report Q2 2025 earnings?
Immuneering Corporation (IMRX) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Immuneering Corporation's Q2 2025 revenue and EPS?
Immuneering Corporation reported eps of $-0.40 for Q2 2025.
Did Immuneering Corporation beat estimates in Q2 2025?
EPS beat the consensus estimate of $-0.40 by $0.00.
How did Immuneering Corporation's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 14.9% from $-0.47.
Where can I find Immuneering Corporation's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001790340-25-000102) and the 10-Q periodic report (0001790340-25-000104) directly on SEC EDGAR. The filing index links above go to sec.gov.